Fig. 2
Dot plots of AD CSF biomarkers in all different (sub)groups. Values are presented as median and interquartile range. Left panels compare controls (triangles), Alzheimer’s disease (AD; squares), and frontotemporal lobar degeneration (FTLD; circles) dementia groups. Right panels compare FTLD subgroups: FTLD-TDP (triangles, squares (representing FTLD-C9orf72 symptomatic mutation carriers), and circles (representing FTLD-GRN symptomatic mutation carriers)), and FTLD-tau (downward triangles)). The dotted line represents the median control level, and the dashed line represents the median AD level. ***p < 0.001, **p < 0.01, *p < 0.05. Aβ amyloid-beta, ns not significant, p-tau181 phosphorylated tau, t-tau total tau